CMS Proposes Updates to Coverage Policy for TAVR

Edwards' Pascal Transcatheter System Receives CE Mark Approval

Evaluation of PARTNER II Compares Cost-Effectiveness of TAVR and SAVR

FDA Approves Expanded Indication For Abbott's MitraClip Device

CT Assessment Before TMVR

By Moderator: Dee Dee Wang, MD, FACC, FASE, FSCCT
Panel: Mayra Guerrero, MD; and Marco Barbanti, MD

Challenging Cases: What Would You Do?

By Ted E. Feldman, MD, MSCAI, FACC, FESC; and Shakeel A. Qureshi, MD, FRCP, FRCPCH

Peripheral Vascular Programs Could Improve Population Health and Grow Volumes

An overview of the steps involved in developing a PAD program to address this underserved patient population.

By Ginger Biesbrock, PA-C, MPH, MPAS, AACC; and Joel Sauer, MBA

Complicated Radial Access During Primary PCI

By Moderator: Pieter C. Smits, MD, PhD, FESC
Panel: Mohamed Abdel-Wahab, MD, FESC; Peter W. Danse, MD; and Valeria Paradies, MD

Planning for Transcatheter Aortic Valve Replacement

By Moderator: Mauricio G. Cohen, MD, FACC, FSCAI
Panel: Santiago Garcia, MD, FACC, FSCAI; William O’Neill, MD; and Molly Szerlip, MD, FACC, FSCAI

On the Paclitaxel Meta-Analysis: A Conversation With Konstantinos Katsanos, MD

Anticipating the 2019 AAA NICE Guidelines

Prof. Loftus shares his thoughts on the impending publication of the UK’s NICE updated guidelines for abdominal aortic aneurysm treatment and the potential effects they may have on practice and patients.

With Ian M. Loftus, MD, FRCS

Highlights From the VIVA Vascular Leaders Forum on Paclitaxel Safety

Genetics and Hereditary Factors of Aortic Disease: Applying What We Know, Exploring What We Don’t

A discussion on the current landscape of genetics research related to diagnosing and treating aortic disease.

With Dianna M. Milewicz, MD, PhD

Case Report: Retrograde Laser Crossing of a Left SFA Occlusion With an Ambiguous Proximal Cap

By Max Amor, MD; and Ahmed Bouzid, MD